Kristopher K. Frese

8.1k total citations · 2 hit papers
27 papers, 3.2k citations indexed

About

Kristopher K. Frese is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Kristopher K. Frese has authored 27 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Kristopher K. Frese's work include Lung Cancer Research Studies (8 papers), Virus-based gene therapy research (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). Kristopher K. Frese is often cited by papers focused on Lung Cancer Research Studies (8 papers), Virus-based gene therapy research (4 papers) and Neuroendocrine Tumor Research Advances (4 papers). Kristopher K. Frese collaborates with scholars based in United Kingdom, United States and Austria. Kristopher K. Frese's co-authors include David A. Tuveson, Florian A. Karreth, Gina M. DeNicola, Charles J. Yeo, Ralph H. Hruban, Eric S. Calhoun, Ian A. Blair, Aarthi Gopinathan, Francesca Scrimieri and Cong Wei and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Kristopher K. Frese

27 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

2011 1.8k citations Gina M. DeNicola, Florian A. Karreth et al. Nature profile →
Maximizing mouse cancer models

2007 500 citations Kristopher K. Frese, David A. Tuveson Nature reviews. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kristopher K. Frese United Kingdom	17	2.2k	918	797	339	298	27	3.2k
Sang‐Gu Hwang South Korea	38	2.4k 1.1×	913 1.0×	826 1.0×	325 1.0×	329 1.1×	123	3.9k
George G. Chen Hong Kong	31	2.2k 1.0×	862 0.9×	1.1k 1.4×	421 1.2×	397 1.3×	119	3.6k
Zhuchu Chen China	34	2.7k 1.2×	836 0.9×	779 1.0×	339 1.0×	336 1.1×	166	3.7k
Tetsuo Mashima Japan	29	3.2k 1.5×	856 0.9×	1.2k 1.5×	262 0.8×	449 1.5×	70	4.4k
William H. Chappell United States	27	2.7k 1.2×	1.3k 1.4×	695 0.9×	418 1.2×	322 1.1×	41	4.0k
Juan Fernando Martínez-Leal Spain	28	2.6k 1.2×	1.5k 1.6×	784 1.0×	281 0.8×	266 0.9×	56	3.6k
Annamaria Biroccio Italy	41	3.7k 1.7×	1.3k 1.4×	679 0.9×	318 0.9×	358 1.2×	117	5.1k
Yiyu Zou United States	23	2.5k 1.1×	1.3k 1.4×	666 0.8×	289 0.9×	616 2.1×	51	3.6k
Markus D. Siegelin United States	39	2.7k 1.2×	786 0.9×	1.0k 1.3×	354 1.0×	382 1.3×	109	4.1k
Insoo Bae United States	32	2.5k 1.1×	1.4k 1.5×	688 0.9×	176 0.5×	261 0.9×	61	3.5k

Countries citing papers authored by Kristopher K. Frese

Since Specialization

Citations

This map shows the geographic impact of Kristopher K. Frese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristopher K. Frese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristopher K. Frese more than expected).

Fields of papers citing papers by Kristopher K. Frese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristopher K. Frese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristopher K. Frese. The network helps show where Kristopher K. Frese may publish in the future.

Co-authorship network of co-authors of Kristopher K. Frese

This figure shows the co-authorship network connecting the top 25 collaborators of Kristopher K. Frese. A scholar is included among the top collaborators of Kristopher K. Frese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristopher K. Frese. Kristopher K. Frese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Revill, Mitchell, Alice Lallo, Melanie Galvin, et al.. (2021). Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer. Nature Communications. 12(1). 6652–6652. 16 indexed citations

Frese, Kristopher K., Melanie Galvin, Mathew Carter, et al.. (2020). Brief report on the clinical characteristics of patients whose samples generate small cell lung cancer circulating tumour cell derived explants. Lung Cancer. 150. 216–220. 6 indexed citations

Revill, Mitchell, Kristopher K. Frese, Melanie Galvin, et al.. (2020). The Rare YAP1 Subtype of SCLC Revisited in a Biobank of 39 Circulating Tumor Cell Patient Derived Explant Models: A Brief Report. Journal of Thoracic Oncology. 15(12). 1836–1843. 48 indexed citations

Lallo, Alice, Sakshi Gulati, Garima Khandelwal, et al.. (2018). Ex vivo culture of cells derived from circulating tumour cell xenograft to support small cell lung cancer research and experimental therapeutics. British Journal of Pharmacology. 176(3). 436–450. 32 indexed citations

Krebs, Matthew, Donna M. Graham, Mahmood Ayub, et al.. (2018). P2.13-33 A Case Report of Exceptional Clinical Response to MEK Inhibition in a Patient with NRAS Mutation Positive NSCLC. Journal of Thoracic Oncology. 13(10). S811–S812. 1 indexed citations

Torres‐Ayuso, Pedro, Sudhakar Sahoo, Garry Ashton, et al.. (2018). Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin. npj Genomic Medicine. 3(1). 15–15. 4 indexed citations

Blackhall, Fiona, Kristopher K. Frese, Kathryn Simpson, et al.. (2018). Will liquid biopsies improve outcomes for patients with small-cell lung cancer?. The Lancet Oncology. 19(9). e470–e481. 48 indexed citations

Khandelwal, Garima, María Romina Girotti, Christopher Smowton, et al.. (2017). Next-Generation Sequencing Analysis and Algorithms for PDX and CDX Models. Molecular Cancer Research. 15(8). 1012–1016. 33 indexed citations

Lallo, Alice, et al.. (2017). Circulating tumor cells and CDX models as a tool for preclinical drug development. Translational Lung Cancer Research. 6(4). 397–408. 65 indexed citations

10.

Foy, Victoria, Katie Baker, Fábio Gomes, et al.. (2017). Targeting DNA damage in SCLC. Lung Cancer. 114. 12–22. 38 indexed citations

11.

Naidu, Srivatsava, Lei Shi, Peter Magee, et al.. (2017). PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways. Scientific Reports. 7(1). 15441–15441. 51 indexed citations

12.

Karreth, Florian A., Kristopher K. Frese, Gina M. DeNicola, Manuela Baccarini, & David A. Tuveson. (2011). C-Raf Is Required for the Initiation of Lung Cancer by K-RasG12D. Cancer Discovery. 1(2). 128–136. 107 indexed citations

13.

DeNicola, Gina M., Florian A. Karreth, Timothy J. Humpton, et al.. (2011). Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature. 475(7354). 106–109. 1756 indexed citations breakdown →

14.

Chung, Sang‐Hyuk, et al.. (2007). Functionally distinct monomers and trimers produced by a viral oncoprotein. Oncogene. 27(10). 1412–1420. 14 indexed citations

15.

Frese, Kristopher K. & David A. Tuveson. (2007). Maximizing mouse cancer models. Nature reviews. Cancer. 7(9). 654–658. 500 indexed citations breakdown →

16.

Frese, Kristopher K., Isabel Latorre, Sang‐Hyuk Chung, et al.. (2006). Oncogenic function for the Dlg1 mammalian homolog of the Drosophila discs‐large tumor suppressor. The EMBO Journal. 25(6). 1406–1417. 69 indexed citations

17.

Lee, Ok-Kyung, Kristopher K. Frese, Jennifer S. James, et al.. (2003). Discs-Large and Strabismus are functionally linked to plasma membrane formation. Nature Cell Biology. 5(11). 987–993. 72 indexed citations

18.

Frese, Kristopher K., Siu Sylvia Lee, Darby L. Thomas, et al.. (2003). Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein. Oncogene. 22(5). 710–721. 76 indexed citations

19.

Kirchhof, Nicole, et al.. (1995). [Intraosseous epidermoid cysts of the toe phalanx in dogs].. PubMed. 108(2). 73–6. 2 indexed citations

20.

Frese, Kristopher K., et al.. (1968). [On the occurrence of cerebrospinal angiopathy (Harding) of pigs in Germany and its position as an independent disease].. PubMed. 81(10). 197–202. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact